Article in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Hyun Jung JiResearch Division for Cyclotron Application, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.ORCID 0009-0009-1350-6426
A-Yeung JangDivision of Infectious Disease, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Seung Hyun HanDepartment of Oral Microbiology and Immunology, DRI, School of Dentistry, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0001-9418-9278
Min-Kyu KimResearch Division for Cyclotron Application, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.ORCID 0000-0001-9594-1396
Charles Euloge LamienDepartment of Nuclear Sciences and Applications, Animal Production and Health Laboratory, Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency, Seibersdorf, Austria.
Viskam WijewardanaDepartment of Nuclear Sciences and Applications, Animal Production and Health Laboratory, Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency, Seibersdorf, Austria.
Ki Bum AhnResearch Division for Cyclotron Application, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
Kyung-Hyo KimDepartment of Pediatrics, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Joon Young SongDivision of Infectious Disease, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-0148-7194
Ho Seong SeoResearch Division for Cyclotron Application, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.ORCID 0000-0002-7103-1344
Funding
International Atomic Energy Agency CRP D32039Korea Atomic Energy Research Institute 523140-26Korea Disease Control and Prevention Agency 2018E240600Ministry of Food and Drug Safety 22202MFDS171National Research Foundation of Korea RS-2022-00164721
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Nanopore SequencingPneumococcal InfectionsSerotypingStreptococcus pneumoniaeCRISPR-Cas SystemsHumansPneumococcal VaccinesRepublic of KoreaSerogroupPneumococcal VaccinesCRISPR-Cas9emerging serotypesnanopore sequencingserotypingStreptococcus pneumoniaevaccine development
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Accurate serotype identification of · full record | OpenQuestion